Dermata Therapeutics reported cash from operations of -$2.50M and free cash flow of -$2.50M for the quarter ended Mar 2026, down 29.3% year over year. This cash flow statement covers 23 quarters of results from Sep 2020 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||
| Net Income | -1.33M | -1.71M | -2.55M | -2.79M | -2.73M | -2.45M | -1.71M | -2.24M | -1.70M | -1.72M | -2.13M | -3.13M | -2.83M | -3.17M | -3.15M | -2.30M | -1.70M | -1.69M | -1.86M | -1.85M | |||
| Share-based Compensation | 0.11M | 0.14M | 0.49M | 0.21M | 0.26M | 0.23M | 0.22M | 0.13M | 0.13M | 0.13M | 0.13M | 0.59M | 0.02M | 0.02M | 0.03M | 0.04M | 0.04M | 0.04M | 0.03M | 0.04M | |||
| Cash from Operations | -0.90M | -2.21M | -1.80M | -2.61M | -1.84M | -2.56M | -1.83M | -1.65M | -1.84M | -1.77M | -1.15M | -2.70M | -2.13M | -3.42M | -2.91M | -1.93M | -2.69M | -1.80M | -1.37M | -2.50M | |||
| Change in Working Capital | |||||||||||||||||||||||
| Change in Inventory | 0.09M | ||||||||||||||||||||||
| Change in Account Payables | 0.39M | -0.11M | -0.25M | 0.15M | -0.05M | -0.13M | 0.01M | -0.00M | -0.06M | 0.04M | 0.39M | -0.04M | 0.40M | -0.37M | -0.10M | 0.10M | -0.46M | 0.05M | -0.08M | -0.05M | |||
| Change in Accured Expenses | 0.31M | -0.16M | 0.26M | -0.15M | 0.23M | 0.26M | -0.59M | 0.29M | -0.47M | 0.20M | 0.32M | -0.21M | 0.01M | 0.47M | 0.13M | 0.14M | -0.70M | 0.05M | 0.52M | -0.45M | |||
| Other Working Capital Changes | 0.51M | -0.20M | -0.17M | 0.60M | -0.44M | -0.15M | -0.09M | -0.27M | 0.37M | -0.17M | -0.09M | -0.13M | 0.25M | -0.07M | 0.09M | ||||||||
| Financing Activities | |||||||||||||||||||||||
| Debt Issuance and Repayment | |||||||||||||||||||||||
| Long-Term Debt Issuances | |||||||||||||||||||||||
| Current Debt | |||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||
| Net Preferred Shares Issued and Repurchased | -0.57M | ||||||||||||||||||||||
| Net Equity Issued and Repurchased | 14.82M | -626.00 | 4.28M | 4.17M | 1.51M | -0.04M | 1.95M | 2.41M | 4.55M | -0.07M | 8.54M | -0.55M | -0.01M | 4.19M | |||||||||
| Misc. | |||||||||||||||||||||||
| Cash from Financing Activities | 14.39M | -626.00 | 4.28M | 200.00 | 4.18M | 1.51M | -0.04M | 1.95M | 2.34M | 4.62M | -0.07M | 8.49M | -0.55M | -0.01M | 4.19M | 1.90M | |||||||
| Change in Cash | -1.63M | 12.18M | -1.80M | -2.61M | 2.44M | -2.56M | -1.83M | 2.53M | -0.33M | -1.81M | 0.81M | -2.70M | 0.21M | 1.20M | -2.98M | 6.56M | -3.24M | -1.82M | 2.86M | -0.58M | |||
| Free Cash Flow | -0.90M | -2.21M | -1.80M | -2.61M | -1.84M | -2.56M | -1.83M | -1.65M | -1.84M | -1.77M | -1.15M | -2.70M | -2.13M | -3.42M | -2.91M | -1.93M | -2.69M | -1.80M | -1.37M | -2.50M | |||
| Net Cash Flow | -0.90M | 12.18M | -1.80M | -2.61M | 2.44M | -2.56M | -1.83M | 2.53M | -0.33M | -1.81M | 0.81M | -2.70M | 0.21M | 1.20M | -2.98M | 6.56M | -3.24M | -1.82M | 2.82M | -0.60M |
Pull Dermata Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=DRMA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "DRMA", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=DRMA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();